Cargando…
Elevated reticulocyte count – a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report
In adults, the haemolytic-uraemic syndrome (HUS) is associated with probable causative factors in the minority of all cases. Cytotoxic drugs are one of these potential causative agents. Although metastatic cancer by itself is a recognized risk-factor for the development of HUS, therapy with mitomyci...
Autores principales: | Serke, S, Riess, H, Oettle, H, Huhn, D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362733/ https://www.ncbi.nlm.nih.gov/pubmed/10188900 http://dx.doi.org/10.1038/sj.bjc.6690242 |
Ejemplares similares
-
Complement therapy in atypical haemolytic uraemic syndrome (aHUS)
por: Wong, Edwin K.S., et al.
Publicado: (2013) -
L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)
por: Kanzelmeyer, Nele Kirsten, et al.
Publicado: (2014) -
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013) -
POS-041 HAEMOLYTIC URAEMIC SYNDROME (HUS) WITH COVID-19 INFECTION: 2 CASE REPORTS. IS THERE A DIRECT LINK?
por: Maharaj, N., et al.
Publicado: (2021) -
Cutaneous involvement in haemolytic uraemic syndrome
por: Neild, G. H., et al.
Publicado: (2013)